Phosphatidylserine/ Prothrombin Antibody (IgM) details
Blood tests with Phosphatidylserine/ Prothrombin Antibody (IgM)
Explore available tests to better understand your results and gain deeper insights into your health.
Panel
Antiphospholipid Antibody Panel
$369.49
The antiphospholipid antibody syndrome (APS) is a clinical-pathologic correlation that includes a clinical event (e.g. arterial or venous thrombosis, pregnancy morbidity) and persistent positive antiphospholipid antibodies (IgM, IgG Cardiolipin or b2GPI antibodies greater than the 99th percentile; or a lupus anticoagulant). International consensus guidelines for APS suggest waiting at least 12 weeks before retesting to confirm antibody persistence. The Systemic Lupus International Collaborating Clinics immunological classification criteria for systemic lupus erythematosus (SLE) include testing for isotype IgA, which has yet to be incorporated into APS criteria. Low level antiphospholipid antibodies may sometimes be detected in the setting of infection, drug therapy or aging.
- Beta-2-Glycoprotein I Antibody (IgA)
- Beta-2-Glycoprotein I Antibody (IgG)
- Beta-2-Glycoprotein I Antibody (IgM)
- Cardiolipin Antibody (IgA) An antibody that attacks the body's own phospholipids (IgA type). One of the markers used to help diagnose antiphospholipid syndrome, which raises the risk of blood clots and pregnancy complications.
- Cardiolipin Antibody (IgG) An antibody that attacks the body's own phospholipids (IgG type). One of the markers used to help diagnose antiphospholipid syndrome, which raises the risk of blood clots and pregnancy complications.
- Cardiolipin Antibody (IgM) An antibody that attacks the body's own phospholipids (IgM type). One of the markers used to help diagnose antiphospholipid syndrome, which raises the risk of blood clots and pregnancy complications.
- Phosphatidylserine/ Prothrombin Antibody (IgG)
- Phosphatidylserine/ Prothrombin Antibody (IgM)